Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes.
- Published In:
- Journal of clinical medicine, 14(10) (2025)
- Authors:
- Bobu, Amelian Madalin, Turliuc, Serban, Cucu, Andrei Ionut, Onofriescu, Alina, Dascalu, Cristina Gena, Costea, Claudia Florida, Patrascanu, Emilia, Morosan, Anca Petruta, Haisan, Anca, Filip, Carmen Nicoleta, Covali, Roxana, Buzduga, Catalin Mihai, Botnariu, Gina, Enache, Irina Iuliana Costache
- Database ID:
- RPEP-10186
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10186APA
Bobu, Amelian Madalin; Turliuc, Serban; Cucu, Andrei Ionut; Onofriescu, Alina; Dascalu, Cristina Gena; Costea, Claudia Florida; Patrascanu, Emilia; Morosan, Anca Petruta; Haisan, Anca; Filip, Carmen Nicoleta; Covali, Roxana; Buzduga, Catalin Mihai; Botnariu, Gina; Enache, Irina Iuliana Costache. (2025). Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes.. Journal of clinical medicine, 14(10). https://doi.org/10.3390/jcm14103536
MLA
Bobu, Amelian Madalin, et al. "Dulaglutide 1.5 mg Significantly Improves Glycemic Control and Lowers LDL-Cholesterol and Body Weight in Romanian Patients with Type 2 Diabetes.." Journal of clinical medicine, 2025. https://doi.org/10.3390/jcm14103536
RethinkPeptides
RethinkPeptides Research Database. "Dulaglutide 1.5 mg Significantly Improves Glycemic Control a..." RPEP-10186. Retrieved from https://rethinkpeptides.com/research/bobu-2025-dulaglutide-15-mg-significantly
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.